Replies to post #11150 on Mymetics Corp (MYMX)

[Phosphene]

Very, very small world amigo.

Glad he's doing well and wish him continued success.

Wager he's still invested here.

https://www.bizjournals.com/sanfrancisco/news/2018/06/07/sutrovax-pneumococcal-vaccine-moncef-slaoui.html

Anticipate more between now and April.

Later

[bow-tie]

UBS Group reaffirmed a “neutral” rating on shares of Sanofi in a research note on Friday, November 30th. Argus lifted their price objective on Sanofi from $48.00 to $50.00 and gave the stock a “buy” rating in a research note on Thursday, November 8th.

Work Harder
Friday, 11/09/18 12:54:49 PM
Re: TheHungryHippo post# 10367
0
Post # of 11155

UBS is a Biopole member as is Anergis

Mymetics is the featured organization

https://www.biopole.ch/company/?community=Biopole+members

UBS fella following MYMX makes one wonder where that 13 mil may come from considering UBS would have been @ the Sachs conference